- Repligen’s $1.5B buy for BioLife; BeOne’s $300M US expansionPlus, news about Lonza, Bachem and Samsung Biologics. 🤝 Repligen to acquire BioLife Solutions: Repligen will pay around $1.5 billion for cell processing service supplier BioLife, 36% of which w…Endpoints · 1d ago↗ source
- STAT+: FDA is urged by advocacy group to ban DTC prescription drug adsA leading advocacy group petitioned the FDA to ban direct-to-consumer advertising of prescription medicines.STAT · 1d ago↗ source
- Expect a clash at today’s FDA peptide panelThe service members who refused the Covid vaccine, the fastest-growing Ebola outbreak in history, and other health news from Morning RoundsSTAT · 1d ago↗ source